Loading…
UK maker of nanopore-based DNA/RNA sequencing devices offering real-time, long-read genetic sequencing technology.
UK maker of nanopore-based DNA/RNA sequencing devices offering real-time, long-read genetic sequencing technology.
Sells the sequencer once and then earns again and again on flow cells and kits, single-use parts that each run consumes, so the number of devices in use and how heavily they run matter more than box sales. It spun out of the University of Oxford and listed in London in 2021.
In one line: A UK Illumina challenger using nanopore sequencing tech.
Moat: narrow (IP / patents, installed base). Patented nanopore sequencing offers unique long-read, portable, real-time capability.
Headquarters: Oxford, UK · Founded: 2005 · Employees: 1,403
Size Oxford Nanopore Technologies (ONT.L) is a United Kingdom Information Technology company (Electronic Equipment/Instruments) with a market value of $2.71B, the 140th largest of 363 United Kingdom companies the cockpit tracks. Shares closed at £205.80 on 6 Nov 2026.
Performance Over six months the shares gained 74.5%, against -25.2% for the median peer and +3.6% for the United Kingdom market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 14.8% over the last twelve months (peer median +6.7%); the operating margin is -54.5% (peer median 9.7%).
Valuation It trades at 8.0× enterprise value to sales against a peer median of 3.6× (8th most expensive of 21).
Capital Return on invested capital runs 43.9 points below its cost of capital (9.7% WACC).
Next results Next results expected around 9 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | £235M | £224M | £183M | £170M | £199M |
| Revenue growth | — | +22% | +8% | -15% | — |
| Gross profit | £142M | £104M | £81.4M | £72.0M | £112M |
| EBITDA | -£72.7M | -£78.5M | -£110M | -£128M | -£30.5M |
| Net income | -£121M | -£145M | -£146M | -£155M | -£91.0M |
| Free cash flow | -£61.2M | -£66.3M | -£114M | -£129M | -£69.2M |
| Capital expenditure | £53.3M | £45.7M | £48.6M | £27.3M | £42.2M |
| Total debt | n/a | £41.5M | £46.0M | £41.7M | £34.1M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies ONT.L | $2.71B | +75% | +15% | -55% | 8.0× | n/a |
| Illumina ILMN | $32.2B | +50% | +6% | 21% | 7.3× | 27.1% |
| Pacific Biosciences of California PACB | $701M | +60% | +2% | -102% | 7.6× | n/a |
| Thermo Fisher Scientific TMO | $257B | +50% | +8% | 19% | 6.2× | 20.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ONT.L | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +2.5% | -11.6% | 3rd highest of 21 |
| 6-month return | +74.5% | -25.2% | highest of 21 |
| Distance from 52-week high | -14.1% | -50.8% | 2nd highest of 21 |
| Revenue growth (TTM) | +14.8% | +6.7% | 10th highest of 21 |
| Operating margin | -54.5% | 9.7% | lowest of 21 |
| EV / Sales | 8.0× | 3.6× | 8th most expensive of 21 |
| ROIC minus cost of capital | -43.9 pp | -0.8 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies ONT.L | United Kingdom | $2.71B | +75% | +15% | -55% | 8.0× | n/a | n/a |
| Focuslight Technologies 688167.SS | China | $2.71B | -44% | +22% | -9% | 19.2× | n/a | n/a |
| Ningbo Sanxing Medical Electric 601567.SS | China | $2.66B | -37% | -11% | 3% | 1.4× | 4.8% | +15.1% |
| Shenzhen CSL Vacuum Science & Technology 688785.SS | China | $2.62B | -21% | -2% | 18% | 27.3× | n/a | n/a |
| Kehua Data 002335.SZ | China | $2.81B | -41% | +5% | 5% | 2.3× | 16.7% | +14.4% |
| GeniuS Electronic Optical 3406.TW | Taiwan | $2.81B | +59% | +16% | 20% | 3.1× | 5.9% | +9.5% |
| Suzhou HYC Technology 688001.SS | China | $2.59B | -31% | +19% | 6% | 7.1× | 37.6% | +5.9% |
| Dexerials 4980.T | Japan | $2.55B | -4% | +5% | 35% | 3.5× | 15.0% | +11.6% |
| Vaisala VAIAS.HE | Finland | $2.54B | +22% | +2% | 16% | 3.6× | 9.7% | +9.5% |
| Ginlong Technologies 300763.SZ | China | $2.98B | -47% | +4% | 11% | 3.5× | 10.0% | +27.2% |
| Shanghai Lingang 600848.SS | China | $3.00B | -9% | -26% | 15% | 8.2× | 12.9% | +15.1% |
| Addsino 000547.SZ | China | $3.02B | -49% | -6% | -54% | 9.2× | n/a | n/a |
| Sineng Electric 300827.SZ | China | $2.35B | -25% | +29% | 12% | 2.4× | n/a | n/a |
| Syntec Technology 7750.TW | Taiwan | $3.15B | -46% | +60% | 25% | 4.9× | 17.2% | +24.3% |
| Keli Sensing Technology (Ningbo) 603662.SS | China | $2.28B | -4% | +24% | 19% | 8.7× | 24.7% | +13.4% |
| GRG Banking Equipment 002152.SZ | China | $3.26B | -25% | 0% | 9% | 1.5× | 4.0% | +13.5% |
| Shenzhen SEICHI Technologies 688627.SS | China | $3.37B | -24% | +65% | 3% | 11.8× | n/a | n/a |
| ULVAC 6728.T | Japan | $2.01B | -34% | +7% | 7% | 0.9× | 14.1% | +8.0% |
| Diebold Nixdorf DBD | United States | $1.96B | -25% | +6% | 9% | 0.7× | -2.0% | -0.5% |
| Goodwe Technologies 688390.SS | China | $1.93B | -51% | +53% | 5% | 1.3× | 17.4% | +41.2% |
| Shenzhen Everbest Machinery Industry 002980.SZ | China | $1.90B | -16% | +64% | 23% | 10.2× | n/a | n/a |